Among daily smokers with an LQA, 23.5% used e-cigarettes, 19.3% used pharmacotherapy only (including NRT), and 57.2% used no product. Cigarette abstinence for 12+ months at W3 was ~10% in each group. Half of the cigarette abstainers in the e-cigarette group were using e-cigarettes at W3. Different methods to help quitting had statistically comparable 12+ month cigarette abstinence at W3 (e-cigarettes vs. no product: Risk Difference (RD) = 0.01, 95% CI: -0.04 to 0.06; e-cigarettes vs. pharmacotherapy: RD = 0.02, 95% CI: -0.04 to 0.09). Likewise, daily e-cigarette users at W2 did not show a cessation benefit over comparable no-e-cigarette users, and this finding was robust to sensitivity analyses. Abstinence for 30+ days at W3 was also similar across products.

E-Cigarettes vs. Pharmacotherapy for Smoking Cessation: Efficacy Results

Although the Food and Drug Administration (FDA) has not approved any e-cigarettes for smoking cessation, adult smokers attempt to use e-cigarettes more frequently than FDA-approved pharmacotherapy aids.

Kennesaw State University

Google

Pharmacotherapy is therapy using pharmaceutical drugs, as distinguished from therapy using surgery, radiation, and movement. 

Pharmacotherapy

Due to the addictive nature of nicotine, significant effort has been put into developing effective methods for smoking cessation. Common approaches include various forms of nicotine replacement therapy and several psychotherapeutic options designed to help individuals stop using tobacco products.

Smoking Cessation Methods

E-Cigarette vs. FDA-Approved Pharmacotherapy Usage for Smoking Cessation

The long-term success of smoking cessation programs is a subject of uncertainty. While these programs often demonstrate effectiveness in the short term, it is not clear whether these positive outcomes are sustained over longer periods.

Effectiveness of Smoking Cessation Programs

Analyze the following scenario and recommend a comprehensive approach to help the individual quit smoking. Justify your recommendation by explaining how your chosen methods address the specific challenges presented.

Learn Before

Related

Learn After